G.L. Pharma GmbH
ATBRA.061985-000
Headquarters
Schloßplatz 1
8502 Lannach
Styria
Austria
Contact
Management
Bernhard Frizberg
Member of the Supervisory Board
Since January 5, 2022
Chair of the y Board Alexander Isola
Supervisor
Since January 5, 2022
Deputy Chair of the y Board Eduard Wünscher
Supervisor
Since January 5, 2022
Ilse Bartenstein
Managing Director
Since October 29, 2007
Johann Bartenstein
Managing Director
Since January 1, 2026
Martin Leopold Bartenstein
Managing Director
Since February 23, 2011
Michael Bartenstein
Managing Director
Since January 1, 2026
Stefan Bartenstein
Member of the Supervisory Board
Since February 6, 2024
Georg StarkFormer
Managing Director
October 27, 2014 – September 2, 2020
Johann DanklmaierFormer
Managing Director
January 11, 2019 – July 9, 2021
Financials
| Year | Revenue | Earnings | Balance Total | Equity Ratio |
|---|---|---|---|---|
| 2024 | 310.307.649 € | 48.768.915 € | 384.516.197 € | 87.5% |
| 2023 | 270.859.000 € | 44.346.000 € | 339.094.000 € | 87.9% |
| 2022 | 246.462.667 € | 43.511.247 € | 0 € | 0.0% |
| 2021 | 210.594.687 € | 37.326.713 € | 0 € | 0.0% |
| 2020 | 187.366.500 € | 33.957.496 € | 0 € | 0.0% |
Industry
NACE 21.20Manufacture of pharmaceutical preparationsISIC 2100Manufacture of pharmaceuticals, medicinal chemical and botanical productsNAICS 325199Basic Chemical ManufacturingNAICS 325411Pharmaceutical and Medicine ManufacturingNAICS 325412Pharmaceutical and Medicine ManufacturingNAICS 325413Pharmaceutical and Medicine ManufacturingNAICS 325414Pharmaceutical and Medicine ManufacturingNAICS 339113Medical Equipment and Supplies ManufacturingUKSIC 21.20Manufacture of pharmaceutical preparationsNACE2025 21.20Manufacture of pharmaceutical preparations
Raw Data
{
"id": "4ec66150-66d0-4940-9be0-6bb9630d3055",
"euId": "ATBRA.061985-000",
"name": "G.L. Pharma GmbH",
"legalForm": "GmbH",
"status": "active",
"foundationDate": "1993-11-19T00:00:00",
"vatId": null,
"hq": {
"line2": null,
"street": "Schloßplatz 1",
"city": "Lannach",
"zipCode": "8502",
"state": "Styria",
"country": "AT",
"latitude": 46.945578100000006,
"longitude": 15.332841126928937
},
"contactData": {
"emails": [
"office@gl-pharma.com"
],
"phones": [],
"websites": [
"https://gl-pharma.com/"
],
"faxes": [
"+43 3135700200"
]
},
"managers": [
{
"name": "Bernhard Frizberg",
"position": "Member of the Supervisory Board",
"startDate": "2022-01-05T00:00:00",
"endDate": null
},
{
"name": "Chair of the y Board Alexander Isola",
"position": "Supervisor",
"startDate": "2022-01-05T00:00:00",
"endDate": null
},
{
"name": "Deputy Chair of the y Board Eduard Wünscher",
"position": "Supervisor",
"startDate": "2022-01-05T00:00:00",
"endDate": null
},
{
"name": "Georg Stark",
"position": "Managing Director",
"startDate": "2014-10-27T00:00:00",
"endDate": "2020-09-02T00:00:00"
},
{
"name": "Ilse Bartenstein",
"position": "Managing Director",
"startDate": "2007-10-29T00:00:00",
"endDate": null
},
{
"name": "Johann Bartenstein",
"position": "Managing Director",
"startDate": "2026-01-01T00:00:00",
"endDate": null
},
{
"name": "Johann Danklmaier",
"position": "Managing Director",
"startDate": "2019-01-11T00:00:00",
"endDate": "2021-07-09T00:00:00"
},
{
"name": "Martin Leopold Bartenstein",
"position": "Managing Director",
"startDate": "2011-02-23T00:00:00",
"endDate": null
},
{
"name": "Michael Bartenstein",
"position": "Managing Director",
"startDate": "2026-01-01T00:00:00",
"endDate": null
},
{
"name": "Stefan Bartenstein",
"position": "Member of the Supervisory Board",
"startDate": "2024-02-06T00:00:00",
"endDate": null
}
],
"industry": {
"isic": [
"2100"
],
"nace": [
"21.20"
],
"nace2025": [
"21.20"
],
"naics": [
"325199",
"325411",
"325412",
"325413",
"325414",
"339113"
],
"uksic": [
"21.20"
],
"wz": []
},
"financials": [
{
"year": 2019,
"currency": "EUR",
"capital": 1000000,
"capitalIsEstimate": false,
"balanceTotal": 0,
"balanceTotalIsEstimate": false,
"earnings": 25282300.02,
"earningsIsEstimate": false,
"earningsCagr": 0,
"earningsCagrIsEstimate": false,
"revenue": 173794317.41,
"revenueIsEstimate": false,
"revenueCagr": 0,
"revenueCagrIsEstimate": false,
"returnOnSales": 14.547253556257688,
"returnOnSalesIsEstimate": false,
"equity": 181016326.29,
"equityIsEstimate": false,
"equityRatio": 0,
"equityRatioIsEstimate": false,
"cash": 32288606.45,
"cashIsEstimate": false,
"receivables": 56184067.35,
"receivablesIsEstimate": false,
"liabilities": 230395710.43,
"liabilitiesIsEstimate": false
},
{
"year": 2020,
"currency": "EUR",
"capital": 1000000,
"capitalIsEstimate": false,
"balanceTotal": 0,
"balanceTotalIsEstimate": false,
"earnings": 33957496.43,
"earningsIsEstimate": false,
"earningsCagr": 34.31331960754098,
"earningsCagrIsEstimate": false,
"revenue": 187366500.01,
"revenueIsEstimate": false,
"revenueCagr": 7.809336232773201,
"revenueCagrIsEstimate": false,
"returnOnSales": 18.123568742644842,
"returnOnSalesIsEstimate": false,
"equity": 206139746.33,
"equityIsEstimate": false,
"equityRatio": 0,
"equityRatioIsEstimate": false,
"cash": 2123506.55,
"cashIsEstimate": false,
"receivables": 42242664.4,
"receivablesIsEstimate": false,
"liabilities": 22079224.76,
"liabilitiesIsEstimate": false
},
{
"year": 2021,
"currency": "EUR",
"capital": 1000000,
"capitalIsEstimate": false,
"balanceTotal": 0,
"balanceTotalIsEstimate": false,
"earnings": 37326712.68,
"earningsIsEstimate": false,
"earningsCagr": 21.507079248399343,
"earningsCagrIsEstimate": false,
"revenue": 210594686.61,
"revenueIsEstimate": false,
"revenueCagr": 10.079365779422321,
"revenueCagrIsEstimate": false,
"returnOnSales": 17.72443231159259,
"returnOnSalesIsEstimate": false,
"equity": 232070741.01,
"equityIsEstimate": false,
"equityRatio": 0,
"equityRatioIsEstimate": false,
"cash": 50416966.98,
"cashIsEstimate": false,
"receivables": 43096684.51,
"receivablesIsEstimate": false,
"liabilities": 15662281.09,
"liabilitiesIsEstimate": false
},
{
"year": 2022,
"currency": "EUR",
"capital": 1000000,
"capitalIsEstimate": false,
"balanceTotal": 0,
"balanceTotalIsEstimate": false,
"earnings": 43511247.4,
"earningsIsEstimate": false,
"earningsCagr": 19.83811921810572,
"earningsCagrIsEstimate": false,
"revenue": 246462667.16,
"revenueIsEstimate": false,
"revenueCagr": 12.34968453091938,
"revenueCagrIsEstimate": false,
"returnOnSales": 17.65429543605204,
"returnOnSalesIsEstimate": false,
"equity": 263849348.41,
"equityIsEstimate": false,
"equityRatio": 0,
"equityRatioIsEstimate": false,
"cash": 1850649.03,
"cashIsEstimate": false,
"receivables": 50790221.47,
"receivablesIsEstimate": false,
"liabilities": 106014445.62,
"liabilitiesIsEstimate": false
},
{
"year": 2023,
"currency": "EUR",
"capital": 1000000,
"capitalIsEstimate": false,
"balanceTotal": 339094000,
"balanceTotalIsEstimate": false,
"earnings": 44346000,
"earningsIsEstimate": false,
"earningsCagr": 15.082547764353492,
"earningsCagrIsEstimate": false,
"revenue": 270859000,
"revenueIsEstimate": false,
"revenueCagr": 11.73183327640659,
"revenueCagrIsEstimate": false,
"returnOnSales": 16.372356096714526,
"returnOnSalesIsEstimate": false,
"equity": 298020000,
"equityIsEstimate": false,
"equityRatio": 87.88713454086478,
"equityRatioIsEstimate": false,
"cash": 46023000,
"cashIsEstimate": false,
"receivables": 44091000,
"receivablesIsEstimate": false,
"liabilities": 12577000,
"liabilitiesIsEstimate": false
},
{
"year": 2024,
"currency": "EUR",
"capital": 1000000,
"capitalIsEstimate": false,
"balanceTotal": 384516196.98,
"balanceTotalIsEstimate": false,
"earnings": 48768915.49,
"earningsIsEstimate": false,
"earningsCagr": 9.471699046209414,
"earningsCagrIsEstimate": false,
"revenue": 310307649.02,
"revenueIsEstimate": false,
"revenueCagr": 13.442329017979437,
"revenueCagrIsEstimate": false,
"returnOnSales": 15.716311100941226,
"returnOnSalesIsEstimate": false,
"equity": 336571433.26,
"equityIsEstimate": false,
"equityRatio": 87.53114586679068,
"equityRatioIsEstimate": false,
"cash": 71818152.67,
"cashIsEstimate": false,
"receivables": 43609242.81,
"receivablesIsEstimate": false,
"liabilities": 15743170.74,
"liabilitiesIsEstimate": false
}
]
}